ATE58381T1 - Fibronectine. - Google Patents

Fibronectine.

Info

Publication number
ATE58381T1
ATE58381T1 AT86304998T AT86304998T ATE58381T1 AT E58381 T1 ATE58381 T1 AT E58381T1 AT 86304998 T AT86304998 T AT 86304998T AT 86304998 T AT86304998 T AT 86304998T AT E58381 T1 ATE58381 T1 AT E58381T1
Authority
AT
Austria
Prior art keywords
binding
fibrin
collagen
useful
polypeptide
Prior art date
Application number
AT86304998T
Other languages
English (en)
Inventor
Francisco E Baralle
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Application granted granted Critical
Publication of ATE58381T1 publication Critical patent/ATE58381T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Inorganic Fibers (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Materials For Medical Uses (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT86304998T 1985-06-28 1986-06-27 Fibronectine. ATE58381T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858516421A GB8516421D0 (en) 1985-06-28 1985-06-28 Fibronectins
EP86304998A EP0207751B1 (de) 1985-06-28 1986-06-27 Fibronectine

Publications (1)

Publication Number Publication Date
ATE58381T1 true ATE58381T1 (de) 1990-11-15

Family

ID=10581489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86304998T ATE58381T1 (de) 1985-06-28 1986-06-27 Fibronectine.

Country Status (10)

Country Link
EP (1) EP0207751B1 (de)
JP (1) JPS6289699A (de)
AT (1) ATE58381T1 (de)
AU (1) AU603059B2 (de)
DE (1) DE3675591D1 (de)
DK (1) DK306386A (de)
ES (1) ES2000178A6 (de)
FI (1) FI862756A (de)
GB (1) GB8516421D0 (de)
ZA (1) ZA864791B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3716513A1 (de) * 1987-05-16 1988-11-24 Basf Ag Proteine mit tnf-wirkung
US5019646A (en) * 1987-08-25 1991-05-28 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
JPH0829098B2 (ja) * 1988-01-05 1996-03-27 寳酒造株式会社 細胞接着活性ポリペプチド
JP2561113B2 (ja) * 1988-02-16 1996-12-04 寳酒造株式会社 細胞接着活性ポリペプチド
JP2561122B2 (ja) * 1988-04-13 1996-12-04 寳酒造株式会社 機能性ポリペプチド
JP2942578B2 (ja) * 1988-06-14 1999-08-30 カイロン コーポレイション 新しい結合特性を有する超酸化物不均化酵素類縁体
JP2561131B2 (ja) * 1988-06-30 1996-12-04 寳酒造株式会社 細胞接着活性ポリペプチド
JP2561526B2 (ja) * 1988-12-02 1996-12-11 寳酒造株式会社 細胞接着活性ポリペプチド
US5679320A (en) * 1988-12-29 1997-10-21 Bio-Technology General Corp. Fibrin binding domain polypeptides and uses and methods of producing same
US7087722B1 (en) * 1988-12-29 2006-08-08 Savient Pharmaceuticals, Inc. Fibrin binding domain polypeptides and uses and methods of producing same
CA2006929C (en) * 1988-12-29 2005-10-18 Rachel Guy Cloning and production of polypeptide analogs of human fibronectin and methods of using such polypeptide analogs
US5270030A (en) * 1988-12-29 1993-12-14 Bio-Technology General Corp. Fibrin binding domain polypeptide and method of producing
WO1990008833A1 (en) * 1989-02-02 1990-08-09 Massachusetts Institute Of Technology Expression of recombinant fibronectin in genetically engineered cells
JP2878341B2 (ja) * 1989-03-03 1999-04-05 学校法人藤田学園 人工機能性ポリペプチド
ATE92107T1 (de) * 1989-04-29 1993-08-15 Delta Biotechnology Ltd N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
US5198423A (en) * 1989-05-26 1993-03-30 Takara Shuzo Co., Ltd. Functional polypeptide containing a cell binding domain and a heparin binding domain of fibronectin
JP2561149B2 (ja) * 1989-05-26 1996-12-04 寳酒造株式会社 機能性ポリペプチド
EP0428266B1 (de) * 1989-10-13 1994-09-28 Takara Shuzo Co. Ltd. Antikrebsmittel
GB9023149D0 (en) * 1990-10-24 1990-12-05 British Bio Technology Proteins and nucleic acids
US5668104A (en) * 1992-03-31 1997-09-16 Toray Industries, Inc. Hematopoietic stem cell growth-promoting compositions containing a fibroblast-derived fragment of fibronectin and a growth factor, and methods employing them in vitro or in vivo
WO1994016085A2 (en) * 1992-12-30 1994-07-21 Zymogenetics, Inc. Hybrid proteins having cross-linking and tissue-binding activities
JP3192067B2 (ja) * 1995-10-09 2001-07-23 科学技術振興事業団 ペプチドとコラーゲン収縮阻害剤
EA003195B1 (ru) 1995-11-13 2003-02-27 Такара Сузо Ко., Лтд. Способ повышения эффективности генного переноса в клетки-мишени с помощью ретровируса
JP2780159B2 (ja) * 1996-04-22 1998-07-30 寳酒造株式会社 機能性ポリペプチド遺伝子
JP2780160B2 (ja) * 1996-04-22 1998-07-30 寳酒造株式会社 機能性ポリペプチド
JP2777986B2 (ja) * 1996-04-22 1998-07-23 寳酒造株式会社 機能性ポリペプチド
US6288214B1 (en) 1996-05-16 2001-09-11 Texas A&M University Systems Collagen binding protein compositions and methods of use
US5922676A (en) * 1996-09-20 1999-07-13 The Burnham Institute Methods of inhibiting cancer by using superfibronectin
GB9726539D0 (en) 1997-12-16 1998-02-11 Univ Dundee Polypeptides, polynucleotides and uses thereof
AU2001278737A1 (en) * 2000-08-15 2002-02-25 Terumo Kabushiki Kaisha Collagen-binding hybrid polypeptide
EP2070542A3 (de) 2001-08-15 2010-01-06 Takara Bio Inc. Verfahren zur verbesserten Kultur von antigenspezifischen zyotoxischen T-Lymphozyten
US7094549B2 (en) * 2001-11-23 2006-08-22 Syn X Pharma, Inc. Fibronectin biopolymer marker indicative of insulin resistance
GB0201273D0 (en) * 2002-01-21 2002-03-06 Isis Innovation Fibronectin variants and screening methods
CN100591760C (zh) 2002-03-25 2010-02-24 宝生物工程株式会社 制备细胞毒性淋巴细胞的方法
US8927273B2 (en) * 2003-08-22 2015-01-06 Takara Bio Inc. Process for producing cytotoxic lymphocytes
US8765469B2 (en) 2005-08-17 2014-07-01 Takara Bio Inc. Method of producing lymphocytes
JP5520811B2 (ja) 2007-04-09 2014-06-11 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー コラーゲン結合領域と副甲状腺ホルモンとの融合タンパク
EP3808365B1 (de) 2011-12-14 2024-01-31 The Board of Trustees of the University of Arkansas Abgabe therapeutischer wirkstoffe über ein kollagenbindungsprotein
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
US11624060B2 (en) 2017-02-10 2023-04-11 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1491218C3 (de) * 1963-06-15 1973-01-04 Spofa Sdruzheni Podniku Pro Zdravotnickou Vyrobu, Prag Blutgefäßprothese und Verfahren zur Herstellung derselben
US3272204A (en) * 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
EP0114887B1 (de) * 1982-08-04 1990-11-28 La Jolla Cancer Research Foundation Polypeptide
JPS59134732A (ja) * 1983-01-21 1984-08-02 Green Cross Corp:The フイブロネクチン・生理活性物質複合体の製造法

Also Published As

Publication number Publication date
JPS6289699A (ja) 1987-04-24
DK306386A (da) 1986-12-29
ES2000178A6 (es) 1988-01-01
DE3675591D1 (en) 1990-12-20
GB8516421D0 (en) 1985-07-31
FI862756A0 (fi) 1986-06-27
AU5931586A (en) 1987-01-08
EP0207751A1 (de) 1987-01-07
EP0207751B1 (de) 1990-11-14
DK306386D0 (da) 1986-06-27
AU603059B2 (en) 1990-11-08
FI862756A (fi) 1986-12-29
ZA864791B (en) 1987-02-25

Similar Documents

Publication Publication Date Title
ATE58381T1 (de) Fibronectine.
DE3872273D1 (de) Verfahren zur herstellung und verwendung von kohlenstoffmolekularsieben.
DE68901106D1 (de) Simultanerzeugung von wasserstoff und kohlendioxid.
DE59010170D1 (de) Ballonsonde zur Thrombosierung von Gefässen
AU4159185A (en) Method of inhibiting binding of von willebrand factor to human platelets and inducing interaction of platelets with vessel walls
EP0293443A4 (de) Herstellung synthetischer dns und deren verwendung bei der synthese grosser polypeptide.
DE3870371D1 (de) Herstellung von wasserstoff und kohlenmonoxid.
DE68911299D1 (de) Enzymelektrode und verfahren zur herstellung.
DE3673478D1 (de) Apparat und system zur erzeugung von lebensinformationssignalen.
DE3177260D1 (de) Fuer plasminogen-aktivator kodierende rekombinante desoxyribonukleinsaeure und verfahren zur herstellung von plasminogen-aktivator-protein daraus.
ATE159297T1 (de) Expression von menschlichen serumalbumin in methylotrophischen hefen
DE68919246D1 (de) Verfahren zur Herstellung von Aminosäuren.
DE3888360D1 (de) Hochspannungsschalter und verfahren zur ansteuerung von verbrauchern mittels des hochspannungsschalters.
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
DE3680632D1 (de) Verfahren zur herstellung von kohlenstoffasern und diese kohlenstoffasern.
ATE140962T1 (de) Dns-klone von menschlichem thrombomodulin
DE3776857D1 (de) Aequoringen-varianten und verfahren zur herstellung von entsprechenden aequorinproteinen.
ATE71658T1 (de) Verfahren zur herstellung von humanlysozym.
ATA205288A (de) Verfahren zur gemeinsamen vergasung von fluessigen und festen, staubfoermigen brennstoffen
DE3683512D1 (de) Verfahren zur optischen isomerisierung von optisch aktiver aminosaeure und verfahren zur herstellung von optisch aktiver aminosaeure.
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
DE3884695D1 (de) Träger für gegossene Teile und Methode zur Verwendung des Trägers.
DE59207095D1 (de) Verfahren zur Herstellung von aktiviertem Protein C
DE3875359D1 (de) Dipeptide, verfahren zur herstellung und verwendung in der bestimmung von proteasen.
DE68919282D1 (de) Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen.